Related Experiment Video
Updated: Mar 7, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Etiology of severe pneumonia in Ecuadorian children
Sivani Jonnalagadda1, Oswaldo Rodríguez2, Bertha Estrella2,3
1Center for Global Health and Development, Boston University School of Public Health, Boston, Massachusetts, United States of America.
Insights
Community-acquired pneumonia in Ecuadorian children is frequently caused by respiratory syncytial virus (RSV) and influenza. Undernutrition is a key risk factor, highlighting the need for interventions and a potential RSV vaccine.
Area of Science:
- Pediatric infectious diseases
- Respiratory pathogen research
- Etiology of community-acquired pneumonia
Background:
- Community-acquired pneumonia (CAP) is a significant cause of child morbidity and mortality in Latin America.
- Etiological studies of pneumonia in Ecuador are limited.
- This study investigated the causes of severe pneumonia in young children in Quito, Ecuador.
Purpose of the Study:
- To determine the bacterial and viral etiology of severe community-acquired pneumonia in children aged 2-59 months in Ecuador.
- To identify risk factors associated with specific respiratory pathogens.
Main Methods:
- Observational study within a randomized clinical trial in Quito, Ecuador.
- Analysis of nasopharyngeal and blood samples using polymerase chain reaction (PCR).
- Evaluation of risk factors for identified respiratory pathogens.
Main Results:
- Respiratory syncytial virus (RSV) was detected in 39.2% of children, human metapneumovirus (hMPV) in 17.5%, and adenovirus in 15.3%.
- Streptococcus pneumoniae was found in 9.2% and Mycoplasma pneumoniae in 0.74%.
- Younger age and underweight status were risk factors for RSV; maternal education and clinical signs were associated with influenza A; younger age and respiratory rate were linked to HPIV-3.
Conclusions:
- RSV and influenza are important pathogens in pediatric pneumonia in Ecuador.
- Modifiable risk factors like undernutrition are significant.
- The findings support the potential future use of an RSV vaccine.
Background:
In Latin America, community-acquired pneumonia remains a major cause of morbidity and mortality among children. Few studies have examined the etiology of pneumonia in Ecuador.
Methods:
This observational study was part of a randomized, double blind, placebo-controlled clinical trial conducted among children aged 2-59 months with severe pneumonia in Quito, Ecuador. Nasopharyngeal and blood samples were tested for bacterial and viral etiology by polymerase chain reaction. Risk factors for specific respiratory pathogens were also evaluated.
Results:
Among 406 children tested, 159 (39.2%) had respiratory syncytial virus (RSV), 71 (17.5%) had human metapneumovirus (hMPV), and 62 (15.3%) had adenovirus. Streptococcus pneumoniae was identified in 37 (9.2%) samples and Mycoplasma pneumoniae in three (0.74%) samples. The yearly circulation pattern of RSV (P = 0.0003) overlapped with S. pneumoniae, (P = 0.03) with most cases occurring in the rainy season. In multivariable analysis, risk factors for RSV included younger age (adjusted odds ratio [aOR] = 1.9, P = 0.01) and being underweight (aOR = 1.8, P = 0.04). Maternal education (aOR = 0.82, P = 0.003), pulse oximetry (aOR = 0.93, P = 0.005), and rales (aOR = 0.25, P = 0.007) were associated with influenza A. Younger age (aOR = 3.5, P = 0.007) and elevated baseline respiratory rate were associated with HPIV-3 infection (aOR = 0.94, P = 0.03).
Conclusion:
These results indicate the importance of RSV and influenza, and potentially modifiable risk factors including undernutrition and future use of a RSV vaccine, when an effective vaccine becomes available.
Trial Registration:
ClinicalTrials.gov NCT 00513929.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pulmonary Cycle: Exhalation
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: